Antibiotic Use in Sexually Transmissible Diseases

Dermatologic Clinics

Volumn 27, Issue 1, 2009, Pages 49-61

  Rosen, Ted ^a,b   Vandergriff, Travis ^a,b   Harting, Mandy ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Donovanosis; Gonorrhea; LGV; STD; Syphilis

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; BENZATHINE PENICILLIN; CEFIXIME; CEFOTAXIME; CEFTIZOXIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; DICLOXACILLIN; DOXYCYCLINE; ERYTHROMYCIN; GENTAMICIN; MINOCYCLINE; QUINOLONE DERIVATIVE; SPECTINOMYCIN; STREPTOMYCIN; SULFANILAMIDE DERIVATIVE; TETRACYCLINE; VACCINE;

ABSCESS; ANTIBIOTIC RESISTANCE; BACTERIAL ENDOCARDITIS; BALANOPOSTHITIS; BITE; CELLULITIS; CONCURRENT INFECTION; CYSTOVAGINAL FISTULA; DRUG EFFICACY; FOURNIER GANGRENE; GASTROINTESTINAL SYMPTOM; GENITAL INJURY; GONORRHEA; GRANULOMA INGUINALE; HEALTH CARE COST; HUMAN; INJECTION SITE PAIN; LYMPHANGITIS; LYMPHOGRANULOMA VENEREUM; MENINGITIS; PENICILLIN ALLERGY; PERIHEPATITIS; PRIORITY JOURNAL; RECTOVAGINAL FISTULA; REVIEW; SEPSIS; SEXUAL DYSFUNCTION; SINGLE DRUG DOSE; SYPHILIS; ULCUS MOLLE; URETHRA STRICTURE; VACCINATION;

ANTI-BACTERIAL AGENTS; HUMANS; SEXUALLY TRANSMITTED DISEASES, BACTERIAL;

EID: 54449101842     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.det.2008.07.002     Document Type: Review

References (84)

1. De Schryver A., and Meheus A. Epidemiology of sexually transmitted diseases: the global picture. Bull World Health Organ 68 5 (1990) 639-654
2. Da Ros C.T., and Schmitt Cda S. Global epidemiology of sexually transmitted diseases. Asian J Androl 10 1 (2008) 110-114
3. World Health Organization. Sexually transmitted infections fact sheet. Available at:. http://www.who.int/mediacentre/factsheets/fs110/en/index.html Accessed October, 2007
4. Wasserheit J.N. Epidemiologic synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis 19 2 (1992) 61-77
5. Dickerson M.C., Johnston J., Delea T.E., et al. The causal role for genital ulcer disease as a risk factor for transmission of human immunodeficiency virus. An application of the Bradford Hill criteria. Sex Transm Dis 23 5 (1996) 429-440
6. Fleming D.T., and Wasserheit J.N. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 75 1 (1999) 3-17
7. Risbud A. Human immunodeficiency virus (HIV) and sexually transmitted diseases (STD). Indian J Med Res 121 4 (2005) 369-376
8. Grosskurth H., Mosha F., Todd J., et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomized controlled trial. Lancet 346 8974 (1995) 530-536
9. Kamali A., Quigley M., Nakiyingi J., et al. Syndromic management of sexually transmitted infections and behaviour change interventions on transmission of HIV-1 in rural Uganda: a community randomized trial. Lancet 361 9358 (2003) 645-652
10. Laxminarayan R., Mills A.J., Breman J.G., et al. Advancement of global health: key messages from the disease control priorities project. Lancet 367 9517 (2006) 1193-1208
11. Centers for Disease Control and Prevention. Trends in reportable sexually transmitted diseases in the United States, 2004-national surveillance data for chlamydia, gonorrhea, and syphilis (2004), U.S. Department of Health and Human Services (National Center for HIV, STD, and TB Prevention), Atlanta (GA)
12. Rothschild B.M. History of syphilis. Clin Infect Dis 40 10 (2005) 1454-1463
13. Rompalo A.M. Can syphilis be eradicated from the world?. Curr Opin Infect Dis 14 1 (2001) 41-44
14. Centers for Disease Control and Prevention. Sexually transmitted disease surveillance, 2006 (2007), U.S. Department of Health and Human Services (National Center for HIV, STD, and TB Prevention), Atlanta (GA)
15. Peterman T.A., and Furness B.W. The resurgence of syphilis among men who have sex with men. Curr Opin Infect Dis 20 1 (2007) 54-59
16. Centers for Disease Control and Prevention. The national plan to eliminate syphilis from the United States (2006), U.S. Department of Health and Human Services (National Center for HIV, STD, and TB Prevention), Atlanta (GA)
17. Golden M.R., Marra C.M., and Holmes K.K. Update on syphilis: resurgence of an old problem. JAMA 290 11 (2003) 1510-1514
18. Hutchinson C.M., Hook III E.W., Shepherd M., et al. Altered clinical presentation of early syphilis in patients with human immunodeficiency virus infection. Ann Intern Med 121 2 (1994) 94-100
19. Zeltser R., and Kurban A.K. Syphilis. Clin Dermatol 22 6 (2004) 461-468
20. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2006. MMWR Morb Mortal Wkly Rep 55 No. RR-11 (2006) 1-94
21. Verdon M.S., Handsfield H.H., and Johnson R.B. Pilot study of azithromycin for treatment of primary and secondary syphilis. Clin Infect Dis 19 3 (1994) 486-488
22. Gruber F., Kastelan M., Cabrijan L., et al. Treatment of early syphilis with azithromycin. J Chemother 12 3 (2000) 240-243
23. Hook III E.W., Martin D.H., Stephens J., et al. A randomized, comparative pilot study of azithromycin versus benzathine penicillin G for treatment of early syphilis. Sex Transm Dis 29 8 (2002) 486-490
24. Riedner G., Rusizoka M., Todd J., et al. Single-dose azithromycin versus penicillin G benzathine for the treatment of early syphilis. N Engl J Med 353 12 (2005) 1236-1244
25. Kiddugavu M.G., Kiwanuka N., Wawer M.J., et al. Effectiveness of syphilis treatment using azithromycin and/or benzathine penicillin in Rakai, Uganda. Sex Transm Dis 32 1 (2005) 1-6
26. Centers for Disease Control and Prevention. Azithromycin treatment failures in syphilis infections-San Francisco, California, 2002-2003. MMWR Morb Mortal Wkly Rep 53 9 (2004) 197-198
27. Lukehart S.A., Godornes C., Molini B.J., et al. Macrolide resistance in Treponema pallidum in the United States and Ireland. N Engl J Med 351 2 (2004) 154-158
28. Katz K.A., and Klausner J.D. Azithromycin resistance in Treponema pallidum. Curr Opin Infect Dis 21 1 (2008) 83-91
29. Moorthy T.T., Lee C.T., Lim K.B., et al. Ceftriaxone for treatment of primary syphilis in men: a preliminary study. Sex Transm Dis 14 2 (1987) 116-118
30. Zhou P., Gu Z., Xu J., et al. A study evaluating ceftriaxone as a treatment agent for primary and secondary syphilis in pregnancy. Sex Transm Dis 32 8 (2005) 495-498
31. Augenbraun M., and Workowski K. Ceftriaxone therapy for syphilis: report from the emerging infections network. Clin Infect Dis 29 5 (1999) 1337-1338
32. Smith N.H., Musher D.M., Huang D.B., et al. Response of HIV-infected patients with asymptomatic syphilis to intensive intramuscular therapy with ceftriaxone or procaine penicillin. Int J STD AIDS 15 5 (2004) 328-332
33. Rolfs R.T., Joesoef M.R., Hendershot E.F., et al. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. The Syphilis and HIV Study Group. N Engl J Med 337 5 (1997) 307-314
34. Bong C.T., Bauer M.E., and Spinola S.M. Haemophilus ducreyi: clinical features, epidemiology, and prospects for disease control. Microbes Infect 4 11 (2002) 1141-1148
35. Sehgal V.N., and Srivastava G. Chancroid: contemporary appraisal. Int J Dermatol 42 3 (2003) 182-190
36. Jones C., Rosen T., Clarridge J., et al. Chancroid: results from an outbreak in Houston, Texas. South Med J 83 12 (1990) 1384-1389
37. Lewis D.A. Chancroid: clinical manifestations, diagnosis, and management. Sex Transm Infect 79 1 (2003) 68-71
38. Brown T.J., Yen-Moore A., and Tyring S.K. An overview of sexually transmitted diseases. Part I. J Am Acad Dermatol 41 4 (1999) 511-532
39. Smith J.L., and Bayles D.O. The contribution of cytolethal distending toxin to bacterial pathogenesis. Crit Rev Microbiol 32 4 (2006) 227-248
40. Jones C.C., and Rosen T. Cultural diagnosis of chancroid. Arch Dermatol 127 12 (1991) 1823-1827
41. Patterson K., Olsen B., Thomas C., et al. Development of a rapid immunodiagnostic test for Haemophilus ducreyi. J Clin Microbiol 40 10 (2002) 3694-3702
42. Tyndall M., Malisa M., Plummer F.A., et al. Ceftriaxone no longer predictably cures chancroid in Kenya. J Infect Dis 167 2 (1993) 469-471
43. Tyndall M.W., Agoki E., Plummer F.A., et al. Single dose azithromycin for the treatment of chancroid: a randomized comparison with erythromycin. Sex Transm Dis 21 4 (1994) 231-234
44. Roy-Leon J.E., Lauzon W.D., Toye B., et al. In vitro and in vivo activity of combination antimicrobial agents on Haemophilus ducreyi. J Antimicrob Chemother 56 3 (2005) 552-558
45. Afonina G., Leduc I., Nepluev I., et al. Immunization with the Haemophilus ducreyi hemoglobin receptor HgbA protects against infection in the swine model of chancroid. Infect Immun 74 4 (2006) 2224-2232
46. Nieuwenhuis R.F., Ossewaarde J.M., van der Meijden W.I., et al. Unusual presentation of early lymphogranuloma venereum in an HIV-1 infected patient: effective treatment with 1 g azithromycin. Sex Transm Infect 79 6 (2003) 453-455
47. Van de Laar M.J., Gotz H., de Zwart O., et al. Lymphogranuloma venereum among men who have sex with men-Netherlands, 2003-2004. MMWR Morb Mortal Wkly Rep 53 42 (2004) 985-988
48. Nieuwenhuis R.F., Ossewaarde J.M., Gotz H.M., et al. Resurgence of lymphogranuloma venereum in Western Europe: an outbreak of Chlamydia trachomatis serovar L2 proctitis in The Netherlands among men who have sex with men. Clin Infect Dis 39 7 (2004) 996-1003
49. Herida M., de Barbeyrac B., Sednaoui P., et al. Rectal lymphogranuloma venereum surveillance in France 2004-2005. Euro Surveill 11 9 (2006) 155-156
50. Meyer T., Arndt R., von Krosigk A., et al. Repeated detection of lymphogranuloma venereum caused by Chlamydia trachomatis L2 in homosexual men in Hamburg. Sex Transm Infect 81 1 (2005) 91-92
51. Kropp R.Y., and Wong T. Emergence of Lymphogranuloma venereum in Canada. CMAJ 172 13 (2005) 1674-1676
52. Ahdoot A., Kotler D.P., Suh J.S., et al. Lymphogranuloma venereum in human immunodeficiency virus-infected individuals in New York City. J Clin Gastroenterol 40 5 (2006) 385-390
53. Ward H., Martin I., Macdonald N., et al. Lymphogranuloma venereum in the United kingdom. Clin Infect Dis 44 1 (2007) 26-32
54. van de Laar M.J. The emergence of LGV in Western Europe: what do we know, what can we do?. Euro Surveill 11 9 (2006) 146-148
55. de Vries H.J., Fennema J.S., and Morre S.A. Lymphogranuloma venereum among men having sex with men; what have we learned so far?. Sex Transm Infect 82 4 (2006) 344
56. Spaargaren J., Schachter J., Moncada J., et al. Slow epidemic of lymphogranuloma venereum L2b strain. Emerg Infect Dis 11 11 (2005) 1787-1788
57. Buntin D.M., Rosen T., Lesher Jr. J.L., et al. Sexually transmitted diseases: bacterial infections. J Am Acad Dermatol 25 (1991) 287-299
58. Herring A., and Richens J. Lymphogranuloma venereum. Sex Transm Infect 82 Suppl 4 (2006) iv23-25
59. Sturm P.D., Moodley P., Govender K., et al. Molecular diagnosis of lymphogranuloma venereum in patients with genital ulcer disease. J Clin Microbiol 43 6 (2005) 2973-2975
60. Morre S., Spaargaren J., Fennema J.S., et al. Molecular diagnosis of lymphogranuloma venereum: PCR-based restriction fragment length polymorphism and real-time PCR. J Clin Microbiol 43 10 (2005) 5412-5413
61. McLean C.A., Stoner B.P., and Workowski K.A. Treatment of lymphogranuloma venereum. Clin Infect Dis 44 Suppl 3 (2007) S147-152
62. Sowmini C.N., Gopalan K.N., and Rao G.C. Minocycline in the treatment of lymphogranuloma venereum. J Am Vener Dis Assoc 2 (1976) 19-22
63. Ballard R.C., Ye H., Matta A., et al. Treatment of chancroid with azithromycin. Int J STD AIDS 7 (1996) 9-12
64. O'Farrell N. Donovanosis. Sex Transm Infect 78 6 (2002) 452-457
65. Lupi O., Madkan V., and Tyring S.K. Tropical dermatology: bacterial tropical diseases. J Am Acad Dermatol 54 4 (2006) 559-578
66. Greenblatt R.B., Dient R.B., and Torpin R. Experimental and clinical granuloma inguinale. JAMA 113 11 (1939) 1109-1116
67. Rosen T., Tchen J.A., Ramsdell W., et al. Granuloma inguinale. J Am Acad Dermatol 11 3 (1984) 433-437
68. Hart G. Donovanosis. Clin Infect Dis 25 1 (1997) 24-30
69. Brennand G.L.P., Santana E.M., and Jardim M.L. Cultivation of Calymmatobacterium granulomatis in mouse peritoneal macrophage monolayer. An Bras Dermatol 74 3 (1999) 357-358
70. Joseph A.K., and Rosen T. Laboratory techniques used in the diagnosis of chancroid, granuloma inguinale, and lymphogranuloma. Dermatol Clin. 12 1 (1994) 1-8
71. Bastian I., and Bowden F.J. Amplification of Klebsiella-like sequences from biopsy samples from patients with donovanosis. Clin Infect Dis 23 6 (1996) 1328-1330
72. Bowden F.J., Mein J., Plunkett C., et al. Pilot study of azithromycin in the treatment of genital donovanosis. Genitourin Med 72 1 (1994) 17-19
73. Merianos A., Gilles M., and Chuah J. Ceftriaxone in the treatment of chronic donovanosis in central Australia. Genitourin Med 70 2 (1994) 84-89
74. Parkash S., and Radhakrishna K. Problemic ulcerative lesions in sexually transmitted diseases: surgical management. Sex Transm Dis 13 3 (1986) 127-133
75. Morris S.R., Klausner J.D., Buchbinder S.P., et al. Prevalence and incidence of pharyngeal gonorrhea in a longitudinal sample of men who have sex with men: the EXPLORE study. Clin Infect Dis 43 10 (2006) 1284-1289
76. Kent C.K., Chaw J.K., Wong W., et al. Prevalence of rectal, urethral, and pharyngeal chlamydia and gonorrhea detected in 2 clinical settings among men who have sex with men: San Francisco, California, 2003. Clin Infect Dis 41 1 (2005) 67-74
77. Rosen T. Unusual presentations of gonorrhea. J Am Acad Dermatol 6 3 (1982) 369-372
78. Ghosn S.H., and Kibbi A.G. Cutaneous gonococcal infections. Clin Dermatol 22 6 (2004) 476-480
79. Mehrany K., Kist J.M., O'Connor W.J., et al. Disseminated gonococcemia. Int J Dermatol 42 3 (2003) 208-209
80. Centers for Disease Control and Prevention. Updated recommended treatment regimens for gonococcal infections and associated conditions (2007), U.S. Department of Health and Human Services (National Center for HIV, STD, and TB Prevention), Atlanta (GA). http://www.cdc.gov/std/treatment/2006/updated-regimens.htm Accessed March 2, 2008
81. Wolf Jr. J.S., Gomez R., and McAninch J.W. Human bites to the penis. J Urol 147 5 (1992) 1265-1267
82. Rosen T., and Conrad N. Genital ulcer caused by human bite to the penis. Sex Transm Dis 26 9 (1999) 527-530
83. Rosen T. Penile ulcer from traumatic orogenital contact. Dermatol Online J 11 2 (2005) 18
84. Griego R.D., Rosen T., Orengo I.F., et al. Dog, cat, and human bites: a review. J Am Acad Dermatol 33 6 (1995) 1019-1029